Market Research Logo

Europe Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Head and Neck Cancer patients study in a new report ‘Europe Head and Neck Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Head and Neck Cancer epidemiology, Head and Neck Cancer diagnosed patients, and Head and Neck Cancer treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Head and Neck Cancer derived from epidemiological analysis, percentage of patients diagnosed with Head and Neck Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Head and Neck Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Head and Neck Cancer prevalence, Head and Neck Cancer diagnosis rate, and Head and Neck Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Head and Neck Cancer Patient Flow
  • Head and Neck Cancer Prevalence
  • Head and Neck Cancer Diagnosed Patients
  • Head and Neck Cancer Treated Patients


1. Head and Neck Cancer: Disease Definition
2. Head and Neck Cancer Patient Flow in Europe
2A. Head and Neck Cancer Prevalence in Europe
2B. Head and Neck Cancer Diagnosed Patients in Europe
2C. Head and Neck Cancer Treated Patients in Europe
3. Head and Neck Cancer Patient Flow in Germany
3A. Head and Neck Cancer Prevalence in Germany
3B. Head and Neck Cancer Diagnosed Patients in Germany
3C. Head and Neck Cancer Treated Patients in Germany
4. Head and Neck Cancer Patient Flow in France
4A. Head and Neck Cancer Prevalence in France
4B. Head and Neck Cancer Diagnosed Patients in France
4C. Head and Neck Cancer Treated Patients in France
5. Head and Neck Cancer Patient Flow in Spain
5A. Head and Neck Cancer Prevalence in Spain
5B. Head and Neck Cancer Diagnosed Patients in Spain
5C. Head and Neck Cancer Treated Patients in Spain
6. Head and Neck Cancer Patient Flow in Italy
6A. Head and Neck Cancer Prevalence in Italy
6B. Head and Neck Cancer Diagnosed Patients in Italy
6C. Head and Neck Cancer Treated Patients in Italy
7. Head and Neck Cancer Patient Flow in UK
7A. Head and Neck Cancer Prevalence in UK
7B. Head and Neck Cancer Diagnosed Patients in UK
7C. Head and Neck Cancer Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Head and Neck Cancer Patient Flow in Europe, 2016
Table 2: Head and Neck Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Head and Neck Cancer Patient Flow in Germany, 2016
Table 4: Head and Neck Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Head and Neck Cancer Patient Flow in France, 2016
Table 6: Head and Neck Cancer Patient Flow Forecast in France, 2016 - 2025
Table 7: Head and Neck Cancer Patient Flow in Spain, 2016
Table 8: Head and Neck Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Head and Neck Cancer Patient Flow in Italy, 2016
Table 10: Head and Neck Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Head and Neck Cancer Patient Flow in UK, 2016
Table 12: Head and Neck Cancer Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Head and Neck Cancer Patient Flow in Europe, 2016
Figure 2: Head and Neck Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Head and Neck Cancer Patient Flow in Germany, 2016
Figure 4: Head and Neck Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Head and Neck Cancer Patient Flow in France, 2016
Figure 6: Head and Neck Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 7: Head and Neck Cancer Patient Flow in Spain, 2016
Figure 8: Head and Neck Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Head and Neck Cancer Patient Flow in Italy, 2016
Figure 10: Head and Neck Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Head and Neck Cancer Patient Flow in UK, 2016
Figure 12: Head and Neck Cancer Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report